Europe charts path to regulate psychedelic medicines as psychiatric treatments

A major Lancet review examines how European regulators can safely approve psychedelic drugs for mental health conditions, signaling a shift toward legitimizing these compounds in mainstream medicine. The framework matters to pharmaceutical companies, healthcare systems, and policymakers weighing clinical benefits against public health concerns.

Originaltitel: The therapeutic potential of psychedelics: the European regulatory perspective